July 21, 2008 Issue | Chemical & Engineering News
 
 

Register for C&EN's Inaugural Virtual Symposium Advances in Drug Discovery and Development on Sept 24th

Featuring Keynotes Greg Verdine and Alexander Kamb, as well as others - Registration is free! http://cenm.ag/symposium

 
Copyright © 2008 American Chemical Society
 

July 21, 2008 Issue

Volume 86, Issue 29
8629cov_opencxd_opt
July 21, 2008 Issue, Vol. 86 | Iss. 29
More and more companies are using fragment-based lead design as a drug discovery strategy
By Sarah Everts
(pp. 15-23)
Features
Business
Preregistration for chemical regulation program settles in after a few teething problems (pp. 27-29)
Government & Policy
Obama is at odds with chemical industry on key energy and trade issues (pp. 35-41)
Back Issues
 

News of the Week

Lightweight Atoms Imaged

New method renders conventional instruments capable of 'seeing' hydrogen atoms
(p.9)

Broader Agenda For Weapons Labs

Half of labs' work will be non-weapons-related science
(p.10)

U.S. Probe Hurts Ranbaxy

Questions about quality spark concerns over buyout
(p.10)

Ashland To Buy Hercules For $3.3 Billion

Deal will create firm focused on additives, paper, and resins
(p.11)

Support For Masters Of Science

Professional science master's degree programs are vital and must be funded, NRC report states
(p.11)

Inside View

Technique provides high-resolution images of object interiors
(p.12)

Roche Suspends HIV Drug Research

Finding nothing new to offer against HIV, firm calls it quits
(p.12)

Court Nixes Power Plant Regulation

EPA must redo rule to curb SO2 and NOx emissions
(p.13)
 

Departments

8629bus1_pillarlogocxd_opt

Business

Preregistration for chemical regulation program settles in after a few teething problems
(pp. 27-29)
DSM's pharma products unit leverages its biotech strength to survive in a tough environment
(pp. 30-31)
N-Methylpyrrolidone enabled environmentally friendlier products, but now it has toxicity problems
(p.32)
More and more companies are using fragment-based lead design as a drug discovery strategy
(pp. 15-23)
8629gov1group

Government & Policy

Obama is at odds with chemical industry on key energy and trade issues
(pp. 35-41)
New program for high-risk research is poised to award first grants, but future funding is unclear
(p.42)
Report challenges data, scientific assumptions of DOE Hanford Waste Cleanup
(p.43)
Lack of mandatory standards leads to widely variable products
(p.44)

Education

Bayer’s worldwide educational programs show students and the public the wonder of science
(pp. 55-57)
8629instru_caidcxd_opt

Science & Technology

Technology and Business news for the laboratory world
(p.54)
Amyloid fibrils are hallmarks of disease but also may provide a basis for advanced nanomaterials
(pp. 48-50)
An artist discovers her visual icon in a life-or-death medical moment
(pp. 52-53)

Newscripts

(p.72)

Editor's Page

Letters

Letters(pp. 6-7)